The Histopathology Department of Nicosia is the only public pathology laboratory in Cyprus, providing histological diagnosis to more than 80% of the Cypriot population. It employs, ten registered Pathologists and eleven qualified technicians, including a Molecular Biologist and a PhD in Molecular Diagnostics. Two of the Technicians are specially trained to support the Medical personnel in biopsy processing and microscopy. The Department offers specialised services on the entire spectrum of pathology, ranging from neuropathology, bone marrow and lymph node pathology, renal pathology, dermatopathology, forensic pathology etc, that refer to modern diagnostic techniques, such as a constantly updated panel of immunohistochemistry and molecular pathology (FISH, CISH, PCR, RT-PCR, etc) . This environment, provides the State with reliable diagnostic pillars, and serves as the sole Oncology Reference Center with the richest archival material in the state, both for the future diagnostic and prognostic, as well as for research purposes. More particularly, it has a well-organised specimen repository including paraffin blocks and histology slides covering biopsies of the last two decades supported by a comprehensively established electronic data management system. This wealth of biospecimen does not only involve biopsies or surgical samples from all Cyprus-based Public Hospitals but, serving as the State’s Reference Center, the NGH Histopathology Department receives samples from across the Private Sector via the two Government-affiliated Oncology Centers (i.e the Bank of Cyprus Oncology Center and the German Oncology Center) for a mandatory second opinion as well as for specialised diagnostics such as FISH and molecular analysis for immunotherapeutics (i.e. PDL-1).
The department employees the WHO revised safety guidelines for diagnostic laboratories and is in the process of the ISO/IEC assessment. The department serves as a teaching affiliate of the UCY Medical School and has been engaged in numerous projects with strategic partners including UCY, CING and EPOS. Both the archival and future bioptic material, would be utilized more effectively for research.